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MS) method was developed to determine pantoprazole sodium (PNT) in human urine. After solid-
phase extraction with SPE cartridge, the urine sample was analysed on a C18 column (symmetry
3.5 lm; 75 mm · 4.6 mm i.d) interfaced with a triple quadrupole tandem mass spectrometer. Posi-
tive electrospray ionization was employed as the ionization source. The mobile phase consisted of
acetonitrile–water (90:10, v/v). The method was linear over a concentration range of 1–
100 ng mL1. The lower limit of quantitation was 1 ng mL1. The intra-day and inter-day relative
standard deviation across three validation runs over the entire concentration range was <10.5%.
The accuracy determined at three concentrations (8.0, 50.0 and 85.0 ng mL1 PNT) was within
±1.25% in terms of relative errors.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.artment of Chemistry, Amrita
rmelaram Post, Bengaluru 560
1216; fax: +91 08028440092.
.L. Bhaskara).
y. Production and hosting by
Saud University.
lsevier1. Introduction
Pantoprazole sodium sesqui hydrate (PNT) is chemically
known as sodium 5-(diﬂuoromethoxy)-2-[[(3,4-dimethoxy-2-
p-methyl]sulﬁnyl]-1H-benzimidazole sesqui hydrate (The
Merck Index, 1997). Pantoprazole inhibits H+/K+ AT Pase
pump function thereby reducing the gastric acid secretion
and healing the acid related conditions. It is used in the treat-
ment of gerd and peptic ulcer. PNT like omeprazole and lan-
soprazole also has a role in the eradication of Helicobacter
pylori infection (Current Index of Medical Specialities, 2005).
The literature survey reveals that only one method available
for characterization of pantoprazole impurities by HPLC–MS
(Reddy et al., 2007), and few methods are available for the
164 B.L. Bhaskara et al.determination of PNT in dosage forms by HPLC with UV
detection.
Ding et al. (2006) have reported chiral HPLC method for
the determination of PNT. In their method PNT was deter-
mined on Chiral column (5 lm, 150 mm · 4.6 mm) with meth-
anol:water (35:65, v/v) as mobile phase. The ﬂow rate was
0.6 mL/min. Enantiomeric separation of PNT has also been re-
ported by Ding et al. (2004). They have used hexane–isopropa-
nol–acetic acid mixture (95:5:0.1, v/v) as the mobile phase at a
ﬂow rate of 2.0 mL/min at 25 C. Xue-Hui et al. (2000) have
reported determination of PNT in capsules by HPLC on a
C18 column with the mobile phase of MeCN–phosphate buffer
(35:65), and UV detection at 288 nm and voltammetry tech-
nique (Nevin, 2003) and HPLC method (Patel et al., 2007).
The reported linearity is in the range of 20–60 lg mL1. All
the above cited methods describe the determination of PNT
in either dosage forms or pure forms. Now a days liquid chro-
matography–tandem mass spectrophotometry (LC–MS–MS),
due to its higher sensitivity and selectivity, has been applied
to the quantiﬁcation of drug in biological samples. The litera-
ture survey revealed that no method has been reported for the
determination of PNT in body ﬂuids.
The literature survey reveals that only few methods are
available for the determination of PNT in dosage forms in
HPLC.
The present study was undertaken to develop a sensitive
and rapid LC–MS–MS method for the determination of
PNT in urine sample using lansoprazole as an internal stan-
dard (Fig. 1). The sample preparation procedure was simple
and a run time of each sample was 4.0 min.
2. Materials and methods
2.1. Apparatus
The LC–MS–MS analysis was performed with an API 2000
(Applied Biosystems) coupled to an HPLC system comprisingN
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Figure 1 Structure of pantoprazole sodium (A) and internal
standard (B).an Agilent 1100 series low pressure quaternary gradient pump
with degasser, autosampler, and the column oven.
2.2. Reagents and standards
All chemicals used were of analytical reagent grade and HPLC
grade acetonitrile and methanol (Merck. Ltd., Mumbai) was
used. Distilled water ﬁltered through 0.22 lm ﬁlter (Millipore)
was used to prepare the solutions.
Milli Q water and acetonitrile was used as mobile phase A
and mobile phase B, respectively. Methanol was used as the
diluent.
Pharmaceutical grade PNT, certiﬁed to be 99.8% pure was
procured from Cipla India Ltd., Mumbai, India, and was used
as received. A stock standard containing 100 lg mL1 PNT
solution was prepared by dissolving accurately weighed
10 mg of pure drug in diluent and diluting to 100 mL in a cal-
ibrated ﬂask with diluent. It was subsequently diluted to ob-
tain a working concentration of PNT.2.3. Procedures
2.3.1. LC–MS conditions
The chromatographic separation was achieved at ambient tem-
perature (25 C) on the column (Symmetry C18, 3.5 lm;
75 mm · 4.6 mm i.d) using the mobile phase of water and ace-
tonitrile in the ratio of 10:90 at a ﬂow rate of 0.6 mL min1.
The mobile phase was degassed before use.
Quantitation was performed using multiple reaction moni-
toring (MRM) of the transitions of m/z 382ﬁ m/z 230 for
pantoprazole and m/z 370.4ﬁ m/z 252 for lansoprazole as
internal standard (IS) with a scan time of 0.2 s per transition.
Fig. 2 shows the product ion spectra of [M+H]+ for pantop-
razole and lansoprazole.
In order to optimize all the MS parameters, a standard
solution (1 lg mL1) of the analyte and IS was infused into
the mass spectrometer.
Analysis was performed in positive mode (ESI) with a turbo
ion spray interface under the conditions: ion source potential,
5500 V, declustering potential, 70 V, focusing potential, 400 V,
capillary temperature, 350 C; entrance potential, 10 V with
nitrogen as nebuliser gas at 25 Psi. The column eluent was
introduced into the electron spray ionization chamber of the
mass spectrometer with a split ratio of 3:7. Mass fragmenta-
tion studies were performed by maintaining the normalized
collision energy at 23 eV.
2.4. Sample preparation
The urine samples collected from healthy volunteers were
spiked with known concentration of PNT and IS and the
resulting sample was diluted 1:1 with water prior to loading
on SPE cartridge (Oasis HLB). The SPE cartridge was condi-
tioned with methanol and water, and then diluted urine was
loaded on. The cartridge was then washed with 5% methanol
and then eluted with 100% methanol. Sample was evaporated
with nitrogen at 40 C. and reconstituted the residue with
water:methanol (1:1) to 500 lL. Then 20 lL of the above solu-
tion was injected into LC–MS–MS for analysis. This proce-
dure was carried out under yellow monochromatic light.
Figure 2 Full scan product ion spectra of pantoprazole (A) and lansoprazole (B).
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Stock solution of PNT was prepared in methanol at the con-
centration of 10 lg mL1. Stock solution of IS was prepared
in methanol at the concentration of 10 lg mL1 and diluted
to 500 ng mL1 with methanol:water (1:1). The stock solutions
were prepared in amber colored bottle and were stored in
refrigerator.
Calibration curve was prepared by diluting the stock
solution with methanol:water (1:1) to get appropriate
concentration. From these dilutions, 20 lL of appropriate
standard solution was added to 1 mL of urine blank to get
an effective concentration of 1, 2, 10, 50, 80 and 100 ng mL1
for PNT.
The quality control (QC) samples were separately prepared
in the blank urine sample at the concentrations of 8, 50 and
85 ng mL1, respectively. The spiked urine samples (standards
and quality controls) were then treated for SPE.3. Results and discussion
3.1. Mass spectrometry
The signal intensity obtained for PNT in positive mode was
much higher than that in negative mode. Then, the possibility
of using electrospray ionization (ESI) or atmospheric pressure
chemical ionization (APCI) sources under positive ion detec-
tion mode was evaluated during the early stage of method
development. ESI spectra revealed higher signals for the mol-
ecule compared to APCI source. Further assay development
was therefore limited to ESI source. The Q1 full spectra of
PNT and IS were dominated by protonated molecules
[M+H]+ and no signiﬁcant solvent adduct ions and fragments
ions were observed. The tuning of the ESI source such as cap-
illary temperature, ﬂow of sheath and auxiliary gas (N2) and
spray voltage on the transition of PNT and IS further im-
proved the sensitivity.
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Although in the aspect of chromatographic separation the
determination of the analyte was not interfered with by endog-
enous substances in the urine sample, yet the ionization of the
analyte, especially of low concentration, was easily suppressed,
which resulted in the linearity of narrow concentration range.
In order to avoid the ion suppression induced by endoge-
nous substances, the inﬂuence of the mobile phase that com-
posed of different percentage of organic phase to the ion
suppression was evaluated during the experiment. It was found
that when mobile phase consists of acetonitrile–water (90:10),
the spiked sample demonstrated good linearity between 1 and
100 ng mL1 for PNT. Under the present chromatographic
conditions, the run time of each sample was 4.0 min. The
retention times were 1.37 and 1.38 min for PNT and IS,
respectively.Figure 3 Representative blank chromato3.3. Method validation
3.3.1. Selectivity
Selectivity was assessed by comparing the chromatograms of
six different batches of blank urine samples (unspiked urine)
with the corresponding spiked urine sample. Fig. 3 shows the
typical chromatograms of a blank, a spiked urine sample with
PNT and IS. There was no signiﬁcant interferences or ion sup-
pression from endogenous substances observed at the retention
times of the analytes (see Fig. 4).
3.4. Linearity of calibration curves and lower limit of
quantiﬁcation
Urine samples were quantiﬁed using ratio of the peak area of
PNT to that of IS as the assay parameter. Peak area ratios
were plotted against PNT concentrations and standard curvesgram for pantoprazole (A) and IS (B).
Figure 4 Representative chromatogram of pantoprazole (1.0 ng mL1) and IS (500 ng mL1).
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x2) least squares linear regression.
To evaluate linearity, urine calibration curves were pre-
pared and assayed in duplicate on three separate days.
Visual inspection of the plotted duplicate calibration curves
and correlation coefﬁcients >0.99 conﬁrmed that the calibra-
tion curves were linear over the concentration ranges of 1–
100 ng mL1 for the analyte.
The lower limit of quantiﬁcation was deﬁned as the lowest
concentration on the calibration curve for which the accept-
able accuracy of ±15% and a precision below ±15% were ob-
tained. The present LC–MS–MS method offered an LLOQ of
1 ng mL1 in 1 mL of urine sample.3.5. Accuracy, intra-day and inter-day precision
The accuracy and precision were also assessed by determin-
ing QC samples at three concentration levels on three dif-
ferent validation days. The accuracy was expressed by
(mean observed concentration)/(spiked concentration) ·
100% and the precision by relative standard deviation
(RSD).
Table 1 summarizes the precision and accuracy for the
PNT evaluated by assaying the QC samples. The intra-day
and inter-day precision were established by performing analy-
ses over a period of 5 days on solutions prepared afresh each
day.
Table 1 Accuracy and intra-day precision.
PNT taken
(ng mL1)
PNT found*
(ng mL1)
Intra-day
RSD (%)
Inter-day
RSD (%)
RE (%)
8 7.9 7.0 10.5 1.25
50 49.8 8.6 8.6 0.40
85 84.3 7.4 4.3 0.82
RE, relative error; RSD, relative standard deviation.
* Mean value of seven determinations.
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Absolute recoveries of PNT at three QC levels were deter-
mined by assaying the samples as described above and com-
paring the peak areas of both PNT and IS with those
obtained from direct injection of the compounds dissolved in
the blank urine.
The recovery of PNT, determined at three concentrations
(8, 50, and 85 ng mL1) were 84.4 ± 5.4%, 83.4 ± 6.4% and
79.4 ± 4.4% (n= 6) respectively.
4. Conclusions
A sensitive LC–MS–MS method for the quantiﬁcation of pan-
toprazole in urine sample was developed and validated. The
method is rapid, sensitive and highly selective with a LOQ of
1 ng mL1. The determination of one urine sample needs
4 min. These results indicated that it is suitable for routine
analysis of large batches of biological samples.References
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